Literature DB >> 10333670

Seroprevalence of herpes simplex virus-type 2 in African-American college women.

L M Lewis1, D I Bernstein, S L Rosenthal, L R Stanberry.   

Abstract

This study examines the relationship between sexual behaviors and prevalence of herpes simplex virus-type 2 (HSV-2) among African-American college women. Subjects (n = 138) were recruited randomly from a state university to participate in a study regarding sexual attitudes and behaviors and to have their blood drawn for type-specific HSV seroprevalence. Sera were analyzed for 96 college women with a mean age of 21 years. Of the 96 women, 29 (30%) were HSV-2 seropositive. The results of this study revealed that a history of sexually transmitted disease was predictive of HSV-2 infection. Number of lifetime partners, however, was not related to HSV-2 seropositivity. Four (31%) of the 13 women who reported only one lifetime partner were seropositive. These findings indicate that for young African-American college women, the risk of being infected with HSV-2 is high even with only one lifetime partner. Behavioral strategies focused on decreasing the number of sexual partners are not likely to be sufficient in preventing the spread of HSV-2 infection among young African-American women. The development and use of alternative approaches to prevent the spread of HSV-2 among young African Americans should be considered.

Entities:  

Mesh:

Year:  1999        PMID: 10333670      PMCID: PMC2608414     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  6 in total

1.  Herpes simplex virus type 2 in the United States, 1976 to 1994.

Authors:  D T Fleming; G M McQuillan; R E Johnson; A J Nahmias; S O Aral; F K Lee; M E St Louis
Journal:  N Engl J Med       Date:  1997-10-16       Impact factor: 91.245

2.  Premarket evaluation of a commercial glycoprotein G-based enzyme immunoassay for herpes simplex virus type-specific antibodies.

Authors:  R L Ashley; L Wu; J W Pickering; M C Tu; L Schnorenberg
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

Review 3.  Herpes simplex virus vaccines.

Authors:  D I Bernstein; L R Stanberry
Journal:  Vaccine       Date:  1999-03-26       Impact factor: 3.641

4.  Compliance with doxycycline therapy in sexually transmitted diseases clinics.

Authors:  M Augenbraun; L Bachmann; T Wallace; L Dubouchet; W McCormack; E W Hook
Journal:  Sex Transm Dis       Date:  1998-01       Impact factor: 2.830

5.  Seroprevalence of herpes simplex virus types 1 and 2 and cytomegalovirus in adolescents.

Authors:  S L Rosenthal; L R Stanberry; F M Biro; M Slaoui; M Francotte; M Koutsoukos; M Hayes; D I Bernstein
Journal:  Clin Infect Dis       Date:  1997-02       Impact factor: 9.079

6.  Identification of women at unsuspected risk of primary infection with herpes simplex virus type 2 during pregnancy.

Authors:  J A Kulhanjian; V Soroush; D S Au; R N Bronzan; L L Yasukawa; L E Weylman; A M Arvin; C G Prober
Journal:  N Engl J Med       Date:  1992-04-02       Impact factor: 91.245

  6 in total
  2 in total

Review 1.  Recent advances: Sexually transmitted infections.

Authors:  R J Gilson; A Mindel
Journal:  BMJ       Date:  2001-05-12

Review 2.  Genital herpes simplex virus infection in the adolescent: special considerations for management.

Authors:  Lawrence R Stanberry; Susan L Rosenthal
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.